In this article , which appeared in the September 15, 2015, issue of Cancer Research (1), there was erroneous duplication of one of the panels of Fig. 7. Specifically, the panel depicting mouse 4 treated with the CD38 antibody SAR650984 and imaged 7 days after injection of the cell line pool JOK-Luc was erroneously duplicated. The erroneous duplicate was presented as mouse 3 treated with an IgG control antibody and imaged 7 days after injection of JOK-Luc. Fig. 7 has now been corrected to show the correct 7-day image of mouse 3 treated with the IgG control.
This change makes more apparent the original scientific conclusion that CD38 is a new target for the therapy of hairy cell leukemia.
The corrected figure appears below. The legend remains the same as originally published. The authors regret the error.
RSS Feeds